EV Group (EVG) of St Florian, Austria, a supplier of wafer bonding and lithography equipment for MEMS (microelectromechanical systems), nanotechnology and semiconductor applications, has introduced the EVG PHABLE exposure system, which is ...
Tags: EVG PHABLE, non-contact litho system, manufacturing photonic components
New information has surfaced in the West, Texas, explosion case that could alter the course of the ongoing investigation into what caused the disaster. As it turns out, West Fertilizer Co., which used to be known as Texas Grain Storage ...
Tags: Texas, fertilizer, plant, lawsuit, Monsanto
The international technology group SCHOTT announced the rebranding of its glass syringes, now known as syriQTM (previously forma 3s). The new name comes on the heels of growth in the field of prefillable syringes, and represents ...
Tags: glass, SCHOTT, rebranding, syringe
Discovery Laboratories, a specialty biotechnology company dedicated to advancing a new standard of respiratory critical care, has announced that the US Food and Drug Administration (FDA) has cleared the company's investigational new drug ...
Tags: Discovery Labs, Medicine
Professor Robert Langer, David H. Koch Institute Professor at the Massachusetts Institute of Technology, will be the honored speaker at the Axalta Distinguished Lectures sponsored by Axalta Coating Systems and hosted by the Department of ...
Tags: Robert Langer, speaker, Axalta, coating
Nuvilex, an international biotechnology company providing cell and gene therapy solutions for the treatment of diseases, has acquired the exclusive worldwide rights to use the cellulose-based live-cell encapsulation technology for the ...
Tags: Nuvilex, Live-Cell Encapsulation Technology, biotechnology, cell, gene
Discovery Laboratories (DSCO), a specialty biotechnology company dedicated to advancing a new standard in respiratory critical care, has initiated the US commercial launch of Surfaxin (lucinactant) Intratracheal Suspension for the ...
Integral Molecular, a biotechnology company, has announced the issuance of a new patent and patent family by the United States Patent and Trademark Office (USPTO) covering the composition of matter for its Lipoparticle technology. This ...
Tags: Lipoparticle Technology, USPTO
Specialist insurer Markel UK has rolled out a new liability product designed to fulfill the specific demands of the rapidly growing UK biomedical and life sciences sector. The sector, which is expected to see strong growth, with ...
Tags: insurer, Life Sciences
US-based biotechnology firm Ignyta has entered into a license agreement with Nerviano Medical Sciences (Nerviano), under which Ignyta will get exclusive global development and marketing rights of tyrosine kinase inhibitors RXDX-101 and ...
Tags: Ignyta, Tyrosine Kinase Inhibitors
Recently, the total size of 10 billion yuan of emerging industries of investment funds was established in Nanjing of Jiangsu. This fund was made of Huatai securities, Soho group and Hony Capital. The first 5 billion yuan raised has been ...
Tags: Emerging Industry, economy, service
Transgenomic, a global biotechnology company, and US-based PerkinElmer have entered into a collaboration agreement for marketing and distributing Transgenomic’s line of molecular diagnostic oncology products in territories outside the ...
Alzheon announced the launch of the company, the securing of initial private financing, and the signing of an exclusive license agreement to a novel clinical drug candidate for Alzheimer’s disease, a family of analogs, and a drug ...
Tags: Alzheon, Alzheimer's Disease
UltraTape Industries, a division of Delphon and leading manufacturer of cleanroom tape and label products, announced the acquisition of the assets of a Silicon Valley label business as part of the company’s ongoing expansion of its ...
Tags: Ultratape, Silicon Valley
Belgian biotechnology firm Cardio3 BioSciences has secured approval from the Italian Medicines Agency (Agenzia Italiana del Farmaco) to start its congestive heart failure cardiopoietic regenerative therapy (CHART-1) European Phase III trial ...
Tags: Cardio3 Biosciences, C-Cure Drug